Genmab — Januar 2019
-
Design, Synthesis and Evaluation of Anti-CD38 Antibody Drug Conjugate
Based on Daratumumab and Maytansinoid https://sci-hub.tw/10.1016/j.bmc.2018.12.024 -
Hvordan ser tidslinjen ud for 2019? Snart besked om at 2 mia er nået. Indsendning til 1. Linje. Årsregnskab med forventninger. Hvad ellers?
-
Ingen tvivl om at Genmabs prognose/budget for 2019 bliver spændende. Håber de guider 3 mia for 2019
-
For Dara salg
-
Jeg syntes at ved hver lille svaghed - bliver vi bombet tilbage 4-5% føler en fjer bliver til høns ... og ved gode nyheder tager folk profit hjem ..der skal meget til at vende stemningen...
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind